Cizzle Bio Submits NIH Grant for Lung Cancer Biomarker Blood Test

Cizzle Bio, a biotechnology company, submitted a grant application to the NIH for a two-year study validating its CIZ1B biomarker for early-stage lung...
Home/KnloSights/Clinical Trial Updates/Cizzle Bio Submits NIH Grant for Lung Cancer Biomarker Blood Test